Literature DB >> 19507329

Schedules of controlled substances: placement of tapentadol into schedule II. Final rule.

.   

Abstract

With the issuance of this final rule, the Deputy Administrator of the Drug Enforcement Administration (DEA) places the substance tapentadol, including its isomers, esters, ethers, salts and salts of isomers, esters and ethers whenever the existence of such isomers, esters, ethers, and salts is possible, into schedule II of the Controlled Substances Act (CSA). As a result of this rule, the regulatory controls and criminal sanctions of schedule II will be applicable to the manufacture, distribution, dispensing, importation, and exportation of tapentadol and products containing tapentadol.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19507329

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  2 in total

Review 1.  Tapentadol immediate release: a review of its use in the treatment of moderate to severe acute pain.

Authors:  James E Frampton
Journal:  Drugs       Date:  2010-09-10       Impact factor: 9.546

2.  Characterizing the Experience of Tapentadol Nonmedical Use: Mixed Methods Study.

Authors:  Suzanne K Vosburg; Taryn Dailey-Govoni; Jared Beaumont; Stephen F Butler; Jody L Green
Journal:  JMIR Form Res       Date:  2022-06-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.